Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    dovitinib AND GIST | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Not yet recruiting Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: dovitinib plus imatinib
2 Recruiting Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Condition: Tumor Pathway Activations Inhibited by Dovitinib
Intervention: Drug: Dovitinib (TKI258)

Indicates status has not been verified in more than two years